Greenwich Lifesciences Inc reports a Return on Equity (ROE) of -412.83%.

What is GLSI's dividend yield?

Greenwich Lifesciences Inc offers a dividend yield of 0.00%.

What is GLSI's Quality Score?

Our AI rates GLSI's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy GLSI?

Our AI Timing Score for GLSI is 28 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does GLSI belong to?

Greenwich Lifesciences Inc is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Greenwich Lifesciences Inc (GLSI) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

GLSI AI Analysis Summary

Our AI summary for GLSI: Greenwich Lifesciences Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -412.83%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 28/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

GLSI

Greenwich Lifesciences Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 55

USD 14.35

0.81 (5.98%) Day Change

Watchlist Portfolio Compare Chart

0.99

D/E

-412.8%

ROE

-207.1%

ROA

0.00%

Div Yield

GREENWICH LIFESCIENCES INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 14.35 Price 0.81 (5.98%) Day Change	NEWS SCORE: 55

GLSI, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	55
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	14.35
PBV / Sector	37.71 / 44,022.72
Earning Per Share	-1.57

PE / Sector	N/A / 19.17
PEG or PE/Growth / Sector	N/A / 1.24
Average 1M Daily Value	2.63 M GREAT
Average 1W Daily Value	1.56 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

47%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-611,495.03 / 98.24
NPM Average (%) / Sector	-611,495.03 / -1,697.63
NPM Change Average (%) / Sector	N/A / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-207.10 / 185,260.96
ROA Average (%) / Sector	-226.20 / 36,684.70
ROA Change Average (%) / Sector	73.33 / 422,221.66 GREAT
ROE (%) / Sector	-412.83 / 243,762.23
ROE Average (%) / Sector	-1,354.50 / 48,758.47
ROE Change Average (%) / Sector	286.74 / 424,968.10 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

Registration Details

Analyze Date	2026-08-05 08:00:16
Symbol	GLSI
Name	GREENWICH LIFESCIENCES INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	14.68 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	198.74 / 9,586.08

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Building 14, Stafford, TX, United States, 77477

Phone: 832-819-3232

Website: https://greenwichlifesciences.com

Sector: Healthcare >> Biotechnology

Description: Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States. Its lead product candidate is GP2, a HER2/neu transmembrane peptide, which is in Phase III clinical trial to prevent breast cancer recurrences in patients. The company also develops FLAMINGO-01, which is in Phase IIb and 3 Phase I clinical trial designed to evaluate the safety and efficacy of GLSI-100 in HER2 positive breast cancer patients. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.